chlorothiazide sodium

Generic: chlorothiazide sodium

Labeler: sagent pharmaceuticals
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name chlorothiazide sodium
Generic Name chlorothiazide sodium
Labeler sagent pharmaceuticals
Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
INTRAVENOUS
Active Ingredients

chlorothiazide sodium 500 mg/18mL

Manufacturer
Sagent Pharmaceuticals

Identifiers & Regulatory

Product NDC 25021-305
Product ID 25021-305_09b4e4be-edc0-4a5e-abb2-1572287f2abe
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA202462
Listing Expiration 2026-12-31
Marketing Start 2019-12-15

Pharmacologic Class

Classes
increased diuresis [pe] thiazide diuretic [epc] thiazides [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 25021305
Hyphenated Format 25021-305

Supplemental Identifiers

RxCUI
484152
UNII
SN86FG7N2K

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name chlorothiazide sodium (source: ndc)
Generic Name chlorothiazide sodium (source: ndc)
Application Number ANDA202462 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 500 mg/18mL
source: ndc
Packaging
  • 1 VIAL in 1 CARTON (25021-305-66) / 18 mL in 1 VIAL
source: ndc

Packages (1)

Ingredients (1)

chlorothiazide sodium (500 mg/18mL)

Linked Drug Pages (2)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "09b4e4be-edc0-4a5e-abb2-1572287f2abe", "openfda": {"unii": ["SN86FG7N2K"], "rxcui": ["484152"], "spl_set_id": ["82dd0bdd-e6bd-48ea-8f58-c8bf71bbfe2c"], "manufacturer_name": ["Sagent Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (25021-305-66)  / 18 mL in 1 VIAL", "package_ndc": "25021-305-66", "marketing_start_date": "20191215"}], "brand_name": "chlorothiazide sodium", "product_id": "25021-305_09b4e4be-edc0-4a5e-abb2-1572287f2abe", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "25021-305", "generic_name": "chlorothiazide sodium", "labeler_name": "Sagent Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "chlorothiazide sodium", "active_ingredients": [{"name": "CHLOROTHIAZIDE SODIUM", "strength": "500 mg/18mL"}], "application_number": "ANDA202462", "marketing_category": "ANDA", "marketing_start_date": "20191215", "listing_expiration_date": "20261231"}